#DXCM

Dexcom’s new chief backs longer‑lasting sensors and health‑tracking apps New CEO Jake Leach will detail 2026 plans, from a revamped Stelo app to wider G7 15 Day CGM access, after revenue grew to more than $4.6B under his predecessor.

2 months ago

#DXCM Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

www.stocktitan.net/news/DXCM/dexcom-enters-...

0 0 0 0

Investors in DexCom, Inc. Urged to Contact Legal Firm Amid Securities Law Violations DexCom, Inc. faces a class action lawsuit for securities law violations. Investors are encouraged to contact The Gross Law Firm before the December 26, 2025 deadline to protect their rights.

3 months ago

Investors in DexCom, Inc. Urged to Contact Legal Firm Amid Securities Law Violations #USA #New_York #Inc. #Securities_Laws #DexCom #DXCM

0 0 0 0

Investors of DexCom, Inc. Urged to Connect with The Gross Law Firm by December 26, 2025 Shareholders of DexCom, Inc. are encouraged to contact The Gross Law Firm before December 26, 2025, regarding potential legal action.

3 months ago

Investors of DexCom, Inc. Urged to Connect with The Gross Law Firm by December 26, 2025 #USA #New_York #Gross_Law_Firm #DexCom #DXCM

0 0 0 0

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States DexCom, Inc., the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will launch in the United States on Dec. 1. G7 15 Day will also be covered for Medicare beneficiaries and has met the category requirements for therapeutic CGM systems set forth by the U.S....

3 months ago

#DXCM Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

www.stocktitan.net/news/DXCM/dexcom-g7-15-d...

0 0 0 0

@lieffcabraser.bsky.social

3 months ago

#DXCM Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

www.stocktitan.net/news/DXCM/dexcom-smart-b...

0 0 0 0

Lieff Cabraser

3 months ago

DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action – Contact Lieff Cabraser #StockNews #DXCM

Learn more here: www.lieffcabraser.com/2025/11/dexc...

0 0 0 0

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ) Dexcom (NASDAQ: DXCM) announced that as of November 7, 2025 Québec will expand RAMQ coverage to include Dexcom Continuous Glucose Monitoring (CGM) for eligible adults (age 18+) living with type 2 diabetes who are treated with intensive insulin therapy (IIT).Eligibility requires IIT (at least three injections/day or insulin pump) plus one or more clinical criteria such as unmet HbA1C targets, frequent hypoglycemia, or impaired hypoglycemia awareness. The release highlights Dexcom G7 features including a 30-minute warm-up, predictive Urgent Low Soon alert (3.1 mmol/L within 20 minutes), waterproof rating (submerged up to eight feet for 24 hours), and Apple Watch connectivity.

4 months ago

#DXCM Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

www.stocktitan.net/news/DXCM/quebec-expands...

0 0 0 0

Class Action Lawsuit Launched Against DexCom, Inc. for Investor Recovery DexCom, Inc. faces a class action lawsuit concerning misleading statements about its glucose monitoring devices. Investors can register to participate in recovery.

4 months ago

Class Action Lawsuit Launched Against DexCom, Inc. for Investor Recovery #United_States #New_York #Shareholders #DexCom #DXCM

0 0 0 0

4 months ago

#DXCM #f76e940a-74f1-4aab-9c9d-c08554d2d8b0 #investing

Origin | Interest | Match

0 0 0 0

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance Revenue grew 22% year-over-year to $1.209 billion on a reported basis and 20% year-over-year on an organic 1 basis. U.S. revenue grew 21% and international revenue grew 22% on a reported basis and 18% on an organic 1 basis, all on a year-over-year basis. GAAP operating income of $242.5 million or 20.1% of revenue, an increase of 480 basis points compared to the...

4 months ago

#DXCM Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

www.stocktitan.net/news/DXCM/dexcom-reports...

0 0 0 0

Stockoscope

@stockoscope.bsky.social

4 months ago

Stock news image

$DXCM: DexCom price target lowered to $94 from $102 at Truist

thefly.com/permalinks/entry.php/id4...

More $DXCM news: https://stockoscope.com/stock/dxcm/news

#DXCM #DexComInc #Healthcare

0 0 0 0

5 months ago

#DXCM #REGN #e3487d43-7bbb-45ff-81b2-0a996ffd6220 #investing

Origin | Interest | Match

0 0 0 0

5 months ago

#DXCM #530359bf-89d8-49f2-84ab-7f2cbf4b6c41 #investing

Origin | Interest | Match

0 0 0 0

Văzdooh

@vazdooh.bsky.social

5 months ago

#DXCM 65-55P spread for Nov. Friday's drop was on no news. This thing can easily go to the COVID low at 45 if the market does not like the next earnings report.

0 0 0 0

5 months ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AMC, #DXCM, #SERV, #OPAD, #PTON

#OptionFlow #OptionsTrading #Trading

0 0 0 0

5 months ago

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#JD, #AMC, #SERV, #BA, #DXCM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

5 months ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#B, #AMC, #DXCM, #QUBT, #SYM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

5 months ago

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #B 10.5x
2. #AMC 8.8x
3. #DXCM 6.3x
4. #QUBT 5.0x
5. #SMCI 3.2x

#OptionFlow #OptionsTrading #Trading

0 0 0 0

Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025 Dexcom (NASDAQ:DXCM), a leader in glucose biosensing, will present significant innovations and clinical evidence at the 61st EASD Conference. The company will introduce Dexcom Smart Basal, a new integrated titration module currently under FDA and CE mark review, designed to simplify basal insulin management.Key clinical findings include: reduced neonatal complications in gestational diabetes using CGM versus fingersticks, optimized glucose control through exercise timing in pregnant Type 1 diabetes patients, and a 65% reduction in hypoglycemic events when switching from fingersticks to Dexcom CGM. New cost-effectiveness data from Japan demonstrates CGM's superiority over fingersticks for Type 2 diabetes patients on insulin therapy.

6 months ago

#DXCM Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025

www.stocktitan.net/news/DXCM/dexcom-spotlig...

0 0 0 0

Kuehn Law Investigates Potential Securities Violations at DexCom, Inc. Kuehn Law is urging DexCom investors to reach out as they investigate possible misconduct by the company's officers regarding revenue disclosures.

6 months ago

Kuehn Law Investigates Potential Securities Violations at DexCom, Inc. #USA #New_York #Kuehn_Law #DexCom #DXCM

0 0 0 0

6 months ago

#DXCM #ABT #8d0ceb24-d4f3-489f-8e30-dff2f9d003fa #investing

Origin | Interest | Match

0 0 0 0

DexCom (DXCM) Q2 Revenue Jumps 15% | The Motley Fool

7 months ago

#DXCM #67bc0651-d151-45c2-8c7c-f68099ad92af #data-news

Origin | Interest | Match

0 0 0 0

Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan Dexcom (NASDAQ:DXCM) reported strong Q2 2025 financial results with revenue growing 15% year-over-year to $1.157 billion. The company achieved GAAP operating income of $212.6 million, representing 18.4% of revenue. Dexcom also announced a CEO succession plan, with Jake Leach set to become CEO effective January 1, 2026, while current CEO Kevin Sayer will transition to executive chairman.Key highlights include FDA clearance for the Dexcom G7 15 Day CGM System, launch of AI-based Smart Food Logging, and enhanced Stelo customer experience. The company raised its 2025 revenue guidance to $4.600-$4.625 billion (14-15% growth) while maintaining guidance for other metrics, including Non-GAAP Operating Margin of approximately 21%.The company maintains a strong financial position with $2.93 billion in cash, cash equivalents, and marketable securities.

7 months ago

#DXCM Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan

www.stocktitan.net/news/DXCM/dexcom-reports...

0 0 0 0

Ontario Expands Drug Coverage: 1.7M Diabetics Can Access Dexcom G7 CGM Through Government Program Major expansion of CGM coverage for Ontario insulin users through ODB program. Includes eligibility for seniors, youth, and special care residents. See coverage details.

7 months ago

#DXCM Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

www.stocktitan.net/news/DXCM/ontario-expand...

0 0 0 0

Dexcom Revolutionizes Diabetes Care with AI That Automatically Tracks Food from Photos - First in US Market New AI technology transforms glucose monitoring by instantly identifying meals from photos. Exclusive to Dexcom's Stelo and G7 devices - see how it works.

7 months ago

#DXCM Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio

www.stocktitan.net/news/DXCM/dexcom-launche...

0 0 0 0

Dexcom's Game-Changing NIL Program Signs 13 New College Athletes, NFL Star Mark Andrews Hosts Signing Day Discover how 21 college athletes across 12 sports are breaking barriers with Dexcom's innovative diabetes management technology. See exclusive signing day details.

7 months ago

#DXCM Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews

www.stocktitan.net/news/DXCM/dexcom-unveils...

0 0 0 0

justin

@justintwhite.me

8 months ago

two more Dexcom G7 sensor failures within three days of each other. and of course it’s as my CGM supplies are running low and i’m waiting for my pharmacy to fill my order.

i can’t wait to talk to my endo about Eversense. tbh, i might switch back to the G6 in the meantime.
#DXCM $DXCM #dexcom

0 0 1 0